Boris S. Naroditsky

2 ta ish

Ministry of Health of the Russian Federation

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

   Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28

   Maqola20216 iqtibos

   ABIABI:AkademIndex/2026.other.554498

2. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

   Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova +29

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.717228